At a glance
- Originator Nonindustrial source
- Class Antihyperlipidaemics; Antiplatelets; Vascular disorder therapies
- Mechanism of Action Adenylate cyclase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis
Most Recent Events
- 19 Dec 1997 No-Development-Reported for Atherosclerosis in Taiwan (Unknown route)
- 07 Jul 1995 New profile
- 07 Jul 1995 Preclinical development for Atherosclerosis in Taiwan (Unknown route)